DUBLIN, January 18, 2022–(BUSINESS WIRE)–The "Global Body Fat Reduction Market By Service Provider, By Gender, By Procedure, By Regional Outlook, Industry Analysis Report and Forecast, 2021 – 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Body Fat Reduction Market size is expected to reach $17.9 billion by 2027, rising at a market growth of 11.9% CAGR during the forecast period.
Key Market Players:
Allergan PLC (AbbVie)
Bausch Health Companies, Inc.
Cutera, Inc.
Alma Lasers Ltd. (Sisram Medical Ltd.)
Vlcc Health Care Limited
Apollo Hospitals Enterprise Limited
Candela Medical Corporation
Sciton, Inc.
Lumenis Ltd.
Cynosure, LLC
Body fat reduction refers to the treatment which majorly includes reducing or removing excessive, undesirable fats from various areas of the body. One of the major causes of weight gain is the deposition of fats which further leads to obesity. Obesity among the kids, young and older generation is drastically increasing across the world. Moreover, obesity increases the occurrence of various kinds of health issues such as cardiac disease, hypertension, high blood pressure, diabetes, cholesterol, and immobility. Thus, there is high popularity of body fat reduction and body reshaping procedures which have been performed with the help of non-invasive and surgical techniques.
Some of the growth catalysts for the body fat reduction market are the rise in demand for body contouring treatments, increasing healthcare spending, and the increase in the obese population. In addition, an inactive lifestyle is a common cause of obesity, physical inactivity, with behavioral risk factors such as smoking, alcohol consumption, and stress are also significantly responsible for the rising cases of obesity around the world.
Moreover, some of the key drivers for the market are an increase in awareness of such health hazards, increasing concerns among the people about healthcare, and growing spending in the healthcare industry. Further, the growth of the body fat reduction market is expected to witness bright growth prospects due to the surge in demand, increased adoption of body contouring procedures, and rising obsessed population.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic has severely impacted the whole aesthetic and beauty market. The demand for all the noninvasive and invasive aesthetic processes was negatively affected during the pandemic, which also include the body fat reduction market. As governments imposed different kinds of rules and regulations like the travel ban, lockdown, and others, due to which medical treatments other than COVID-19 were put on complete halt.
Moreover, as body fat reduction is merely a procedure to reduce fat and is non-fatal, many hospitals and clinics were not performing these procedures. In addition, as body fat reduction procedures are considered as non-essential activities, people had reduced their expenditure on these procedures which had hampered the growth of the market during the pandemic.
Market Growth Factors:
Emerging trend and popularity of cosmetic surgeries
As the demand for Cosmetic surgeries has gained high momentum around the world, the demand for body fat reduction procedures and techniques has been increased in the last couple of years. People are highly shifting towards these procedures in order to remove extra fat, thereby improving their overall appearance. Moreover, the rise in aesthetic awareness has motivated a considerable number of people to choose these procedures. Additionally, professionals perform several procedures to improve any particular area of the body that has excess fat or untoned skin.
Rise in disposable income of the consumers
The surge in disposable income has motivated many consumers to spend on different luxurious activities and cosmetic products. In addition, people have started to give more time and energy to their looks and appearance. As a result, the demand for body contouring procedures including body fat reduction has increased drastically in the last couple of years. In addition, the demand for beauty and aesthetic products is also increasing globally. Additionally, with the higher living standard, people have also increased their spending on beauty & appearance which has directly motivated them to prefer body fat reduction techniques.
Market Restraining Factor:
High cost of these procedures
The procedure performed for body fast reduction includes a number of different devices, tools, and medications. As a result, these procedures become highly costly for reshaping or contouring a person's body. Additionally, the rise in technological developments of body contouring devices is eventually contributing to the overall cost of these procedures and thus, making it difficult for middle-class people to opt for body contouring procedures including body fat reduction. Thus, these factors are instrumental in hampering market growth.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
2.1 Introduction
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Body Fat Reduction Market by Service Provider
Chapter 4. Global Body Fat Reduction Market by Gender
Chapter 5. Global Body Fat Reduction Market by Procedure
Chapter 6. Global Body Fat Reduction Market by Region
Chapter 7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/tzv5h4
View source version on businesswire.com: https://www.businesswire.com/news/home/20220118005810/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Shares of clinical-stage biotech companies can skyrocket in a short period based on positive clinical and regulatory news. With that said, let's look at two clinical-stage biotechs that currently boast significant upside potential if we go by average price targets assigned by Wall Street analysts: CRISPR Therapeutics (NASDAQ: CRSP) and Axsome Therapeutics (NASDAQ: AXSM).
(TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web," or the "Company"), the market leader in full spectrum hemp extract products, today announced a national distribution agreement with GNC, a leading specialty retailer of nutritional products with more than 2,000 locations in the United States. Initial shipments of six varieties of Charlotte's Web Gummies will be available for purchase at GNC retail locations across 24 states, with the intent to expand into additional stat
A fourth vaccine boost lifted antibodies, but omicron infections persisted, according to an unpublished study at an Israeli hospital
Photo Illustration by The Daily Beast/HandoutA Minnesota woman whose husband neared death from COVID appealed to the courts to force his hospital to halt their plans to pull the plug on the man’s ventilator.Scott Quiner, 55, a reportedly unvaccinated man who had been battling COVID in Mercy Hospital’s ICU in Coon Rapids since November, was set to have his ventilator shut off on Jan. 13, according to a petition filed in court one day before the deadline by his wife, Anne Quiner.Quiner said the de
Preliminary research showed fourth dose of the Pfizer vaccine boosts antibodies, but did not prevent Omicron infections
Signs that the omicron-driven surge of coronavirus cases may be peaking in northeastern states where it took hold earliest weighed against continued stress on hospitals on Tuesday, as the national case rate stood at a record of about 800,000 a day.
Moderna is looking to expand the use of mRNA drug technology to other vaccines. So far, investors haven't been impressed by progress on a flu shot.
Rona MacInnes, 54, was determined to do everything possible to protect her elderly mother as her family prepared to gather for Christmas in Pennington, N.J. With her son returning from study in Dublin, MacInnes hoped serial at-home coronavirus tests would catch a coronavirus infection he might bring home. The college junior would take six rapid tests before the holiday, all of which returned negative results. But it would become clear only later – after he had spent time with his grandmother – t
The FDA has approved AbbVie Inc's (NYSE: ABBV) Rinvoq (upadacitinib) for atopic dermatitis in adults and children 12 years of age and older. The approval covers moderate to severe atopic dermatitis in patients whose disease did not respond to previous treatment, not well controlled with other pills or injections, or when the use of other pills or injections is not recommended. Related content: Benzinga's Full FDA Calendar. Rinvoq 15 mg once daily can be initiated in adults and children 12 years
When the pandemic settles down, CEO Paul Hudson says, "We’ll have the global machine that knows how to get it done.” “We either win with the vaccine we have or, we’ll win with mRNA,” he adds.
A so-called "sachet economy" has emerged as high inflation makes everyday items too expensive for many.
The struggle highlights the fragility of India's healthcare system as another wave of the coronavirus fueled by the Omicron variant gathers momentum.
Powecom is one of the only KN95 mask brands authorized by the FDA.
Rochelle Walensky, director of the Centers for Disease Control and Prevention, said in an interview with the Wall Street Journal that the messaging around the COVID-19 pandemic and changing guidance should have been clearer.State of play: Walensky is being coached by media experts and is planning to have more press briefings by herself in order to ensure that CDC is seen as an independent, scientific entity, rather than as a political one, the Journal reports.Get market news worthy of your time
Health Canada approved Pfizer Inc's (NYSE: PFE) oral antiviral treatment for mild to moderate cases of COVID-19 in adults. The approval covers adults with mild to moderate COVID-19 who are at high risk of progressing to hospitalization or death. The active ingredient nirmatrelvir in Paxlovid works by stopping the virus from replicating. Related: Pfizer's Paxlovid Scores FDA Approval, First Oral Antiviral For COVID-19 In US. The drug is intended for after diagnosis of COVID-19 and within five day
The COVID death toll in America surpassed 850,000 over the weekend. Find out Hudson County's numbers and where to get a test.
NY reported far fewer coronavirus cases in the week ending Sunday, adding 360,560 cases. That's down 39% and continues promising trend. What to know
Aside from tea, coffee is one of the most popular drinks in the entire world. This isn't surprising to most people, especially because of its enticing flavors and energy-boosting properties.Along with its great taste, coffee also has many health benefits. In fact, coffee has been known to lower risk of depression, enhance weight loss, reduce your risk of heart disease, as well as other chronic diseases.Not only that, but coffee is also one of the best drinks you can have for memory loss, as well
A long-standing commitment to public-private partnerships offer an example to countries about the possibilities of treating deadly diseases.
Republican leader claims Fauci is a ‘petty tyrant’ who got Covid wrong

source